Therapeutic role of lymphadenectomy for cervical cancer

Cancer

Volumn 117, Issue 2, 2011, Pages 310-317

  Shah, Monjri ^a   Lewin, Sharyn N ^a,b   Deutsch, Israel ^a,b   Burke, William M ^a,b   Sun, Xuming ^a   Herzog, Thomas J ^a,b   Wright, Jason D ^a,b  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b Department of Medicine   (United States)

Author keywords

cervical cancer; lymph node dissection; lymphadenectomy; radical hysterectomy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DELAYED DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; NEGRO; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; THERAPY EFFECT; UTERINE CERVIX CANCER;

ADULT; AGED; FEMALE; HUMANS; LYMPH NODE EXCISION; MIDDLE AGED; PROGNOSIS; SEER PROGRAM; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 78650977474     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25408     Document Type: Article

References (29)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ., Cancer statistics, 2009. CA Cancer J Clin. 2009; 59: 225-249.
2. Landoni F, Maneo A, Colombo A, et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet. 1997; 350: 535-540.
3. Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F., Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol. 1990; 38: 352-357.
4. Tanaka Y, Sawada S, Murata T., Relationship between lymph node metastases and prognosis in patients irradiated postoperatively for carcinoma of the uterine cervix. Acta Radiol Oncol. 1984; 23: 455-459.
5. Tinga DJ, Timmer PR, Bouma J, Aalders JG., Prognostic significance of single versus multiple lymph node metastases in cervical carcinoma stage IB. Gynecol Oncol. 1990; 39: 175-180.
6. Desch CE, McNiff KK, Schneider EC, et al. American Society of Clinical Oncology/National Comprehensive Cancer Network Quality Measures. J Clin Oncol. 2008; 26: 3631-3637.
7. Miller DS., Advanced endometrial cancer: Is lymphadenectomy necessary or sufficient? Gynecol Oncol. 2006; 101: 191-193.
8. Chan AD, Essner R, Wanek LA, Morton DL., Judging the therapeutic value of lymph node dissections for melanoma. J Am Coll Surg. 2000; 191: 16-22; discussion 22-23.
9. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA., Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007; 99: 433-441.
10. Cragun JM, Havrilesky LJ, Calingaert B, et al. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol. 2005; 23: 3668-3675.
11. Gajra A, Newman N, Gamble GP, Kohman LJ, Graziano SL., Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. J Clin Oncol. 2003; 21: 1029-1034.
12. Kilgore LC, Partridge EE, Alvarez RD, et al. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol. 1995; 56: 29-33.
13. Krag DN, Single RM., Breast cancer survival according to number of nodes removed. Ann Surg Oncol. 2003; 10: 1152-1159.
14. Sosa JA, Diener-West M, Gusev Y, et al. Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer. Ann Surg Oncol. 1998; 5: 140-149.
15. Tepper JE, O'Connell MJ, Niedzwiecki D, et al. Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol. 2001; 19: 157-163.
16. Weir L, Speers C, D'Yachkova Y, Olivotto IA., Prognostic significance of the number of axillary lymph nodes removed in patients with node-negative breast cancer. J Clin Oncol. 2002; 20: 1793-1799.
17. Surveillance, Epidemiology, and End Results, SEER Stat Database: Incidence-SEER 9 Regs Limited-Use, Nov 2006 Sub (1973-2004), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2007, based on the November 2006 submission. Accessed October 1, 2007.
18. The Surveillance, Epidemiology, and End Results (SEER) Program, Data Quality. National Cancer Institute, 2007. Accessed October, 2007.
19. Pieterse QD, Kenter GG, Gaarenstroom KN, et al. The number of pelvic lymph nodes in the quality control and prognosis of radical hysterectomy for the treatment of cervical cancer. Eur J Surg Oncol. 2007; 33: 216-221.
20. Hricak H, Gatsonis C, Chi DS, et al. Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183. J Clin Oncol. 2005; 23: 9329-9337.
21. Wright JD, Dehdashti F, Herzog TJ, et al. Preoperative lymph node staging of early-stage cervical carcinoma by [18F] -fluoro-2-deoxy-D-glucose-positron emission tomography. Cancer. 2005; 104: 2484-2491.
22. Chou HH, Chang TC, Yen TC, et al. Low value of [18F] -fluoro-2-deoxy-D- glucose positron emission tomography in primary staging of early-stage cervical cancer before radical hysterectomy. J Clin Oncol. 2006; 24: 123-128.
23. Sironi S, Buda A, Picchio M, et al. Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT. Radiology. 2006; 238: 272-279.
24. Frumovitz M, Ramirez PT, Levenback CF., Lymphatic mapping and sentinel lymph node detection in women with cervical cancer. Gynecol Oncol. 2008; 110: S17-20.
25. Altgassen C, Hertel H, Brandstadt A, Kohler C, Durst M, Schneider A., Multicenter validation study of the sentinel lymph node concept in cervical cancer: AGO Study Group. J Clin Oncol. 2008; 26: 2943-2951.
26. Bansal N, Herzog TJ, Shaw RE, Burke WM, Deutsch I, Wright JD., Primary therapy for early-stage cervical cancer: radical hysterectomy vs radiation. Am J Obstet Gynecol. 2009; 201: 485 e1-9.
27. Brooks SE, Chen TT, Ghosh A, Mullins CD, Gardner JF, Baquet CR., Cervical cancer outcomes analysis: impact of age, race, and comorbid illness on hospitalizations for invasive carcinoma of the cervix. Gynecol Oncol. 2000; 79: 107-115.
28. Patel DA, Barnholtz-Sloan JS, Patel MK, Malone JM, Jr, Chuba PJ, Schwartz K., A population-based study of racial and ethnic differences in survival among women with invasive cervical cancer: analysis of Surveillance, Epidemiology, and End Results data. Gynecol Oncol. 2005; 97: 550-558.
29. Peters WA, 3rd, Liu PY, Barrett RJ, 2nd, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000; 18: 1606-1613.